185 related articles for article (PubMed ID: 16900525)
21. Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study.
Hoeijmakers YM; Sweep F; Lok C; Ottevanger PB
BJOG; 2020 Aug; 127(9):1139-1145. PubMed ID: 32141676
[TBL] [Abstract][Full Text] [Related]
22. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of surgical management combined with chemotherapy in the treatment of drug-resistant gestational trophoblastic neoplasm].
Feng FZ; Xiang Y; Cao Y; Li L; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):728-31. PubMed ID: 19087536
[TBL] [Abstract][Full Text] [Related]
24. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
25. [Trophoblastic diseases].
ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the response to chemotherapy in gestational trophoblastic neoplasia with vaginal metastases.
Ghaemmaghami F; Behroozi S; Mousavi A; Ashrafgangooei T; Gilani MM; Behtash N; Ghanbari Z
Arch Gynecol Obstet; 2008 Oct; 278(4):315-8. PubMed ID: 18293004
[TBL] [Abstract][Full Text] [Related]
27. Gestational trophoblastic tumor with liver metastasis after misoprostol abortion.
Mousavi SA; Behnamfar F
Arch Gynecol Obstet; 2009 Apr; 279(4):587-90. PubMed ID: 18762963
[TBL] [Abstract][Full Text] [Related]
28. Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?
Miller CR; Chappell NP; Sledge C; Leath CA; Phippen NT; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2017 Jan; 144(1):125-129. PubMed ID: 27816248
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
Cagayan MS; Gacoba MC
J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
Wan X; Xiang Y; Yang X; Wu Y; Liu N; Chen L; Dong R
J Reprod Med; 2007 Oct; 52(10):941-4. PubMed ID: 17977170
[TBL] [Abstract][Full Text] [Related]
31. Practical issues in the management of low-risk gestational trophoblast tumors.
Savage P; Seckl M; Short D
J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
Zhou Y; Feng FZ; Xiang Y; Wan XR
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
[TBL] [Abstract][Full Text] [Related]
33. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
[TBL] [Abstract][Full Text] [Related]
34. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
[TBL] [Abstract][Full Text] [Related]
35. Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women.
Braga A; Maestá I; Michelin OC; Delmanto LR; Consonni M; Rudge MV; Belfort P
Gynecol Oncol; 2009 Mar; 112(3):568-71. PubMed ID: 19108876
[TBL] [Abstract][Full Text] [Related]
36. Current management of gestational trophoblastic diseases.
Berkowitz RS; Goldstein DP
Gynecol Oncol; 2009 Mar; 112(3):654-62. PubMed ID: 18851873
[TBL] [Abstract][Full Text] [Related]
37. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.
Zhao Y; Zhang W; Duan W
J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571
[TBL] [Abstract][Full Text] [Related]
38. Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial.
You B; Deng W; Hénin E; Oza A; Osborne R
Int J Gynecol Cancer; 2016 Jan; 26(1):208-15. PubMed ID: 26569059
[TBL] [Abstract][Full Text] [Related]
39. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
